Japan's exports of basic pharmaceutical products and preparations to Malaysia saw fluctuations from 2013 to 2023, starting at $18.077 million in 2013 and reaching $22.829 million in 2023. The year-on-year growth rates varied significantly, with notable increases in 2016 (11.16%) and 2020 (7.53%), and decreases in 2018 (-4.92%) and 2022 (-7.08%). However, the overall trend from 2013 to 2023 showed a positive trajectory. The compound annual growth rate (CAGR) over the last five years (2018-2023) was 2.64%.
The forecasted data from 2024 to 2028 suggest a steady increase in export values, reaching $25.169 million by 2028. The forecasted five-year CAGR is 1.41%, indicating moderate growth. Future trends to watch for include changes in healthcare regulations, economic conditions in both Japan and Malaysia, and global pharmaceutical market dynamics. It will also be important to monitor the impact of technological advancements and emerging markets on these exports.
